PeptideStack
5.2kquestions
20kanswers
220users

Is STEP 4 a fair comparison of orforglipron against its comparator arm?

Asked 5 Mar 2026Modified 5 months agoViewed 4.8k times
This question was closed as primarily opinion-based.Closed 9 Mar 2026. Answers already posted are preserved; new answers are not accepted. Questions here need a factual basis on which they can be answered.
23

Numbers first: STEP 4 · orforglipron.

I am asking for verification rather than opinion, ideally with something I can read myself.

It is possible the evidence exists and I am searching for the wrong term.

What would count as evidence here, and does it exist?

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questionssemaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questionstirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

162 questionscagrisema
cagrisema

A fixed-ratio combination of cagrilintide, a long-acting amylin analogue, with semaglutide, studied in the REDEFINE programme. Questions here…

14 questions
shareeditfollowflag
TW
askedtare_weight47k385 Mar 2026
The timing signature is the useful part. Everything else is confounded. – h_pergande 4 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 4.8k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.